You searched for supplemental oxygen

Your search for supplemental oxygen returned 5 results

Sort Results:

Relevant Recent

News

Tocilizumab Shortage Prompts Temporary REMS Change for CAR T-Cell Therapy

December 14, 2021

Shortly after an EUA was issued, Genentech announced that tocilizumab (marketed under the brand name Actemra) was in shortage.

News

Convalescent Plasma Not Efficacious in Hospitalized COVID-19 Patients

December 14, 2021

No significant difference versus placebo observed for hospitalized patients with COVID-19 receiving noninvasive supplemental oxygen

News

FDA Authorizes Emergency Use of Actemra for COVID-19

June 28, 2021

The EUA was issued based on 4 randomized controlled clinical trials that evaluated the efficacy and safety of Actemra in more than 5500 hospitalized patients with COVID-19.

Drugs in the Pipeline

Mixed Results for Baricitinib in Trial of Hospitalized COVID-19 Patients

April 8, 2021

Findings showed that the trial did not meet statistical significance on the primary endpoint.

News

Small Study Tests Colchicine for Moderate-to-Severe COVID-19

February 8, 2021

Authors call for larger clinical trials to further evaluate the efficacy and safety of colchicine as an adjunctive therapy for COVID-19

Your search for supplemental oxygen returned 5 results

Active Filters

Tocilizumab Shortage Prompts Temporary REMS Change for CAR T-Cell Therapy

Convalescent Plasma Not Efficacious in Hospitalized COVID-19 Patients

FDA Authorizes Emergency Use of Actemra for COVID-19

Mixed Results for Baricitinib in Trial of Hospitalized COVID-19 Patients

Small Study Tests Colchicine for Moderate-to-Severe COVID-19